E
Emilio Ojeda Gutierrez
Publications - 1
Citations - 184
Emilio Ojeda Gutierrez is an academic researcher. The author has contributed to research in topics: Paroxysmal nocturnal hemoglobinuria & Eculizumab. The author has an hindex of 1, co-authored 1 publications receiving 116 citations.
Papers
More filters
Journal ArticleDOI
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.
Austin G. Kulasekararaj,Anita J. Hill,Scott T. Rottinghaus,Saskia Langemeijer,Richard A. Wells,F. Ataulfo Gonzalez-Fernandez,Anna Gaya,Jong Wook Lee,Emilio Ojeda Gutierrez,Caroline I. Piatek,Jeff Szer,Antonio M. Risitano,Shinji Nakao,Eric Bachman,Lori Shafner,Andrew I. Damokosh,Stephan Ortiz,Alexander Röth,Régis Peffault de Latour +18 more
TL;DR: Patients with PNH may be safely and effectively switched from labeled-dose eculizumab administered every 2 weeks to ravulizumabs administered every 8 weeks, and no meningococcal infections or discontinuations due to adverse events occurred.